Medicines that act on the GLP-1 system can cause gastrointestinal symptoms capable of disrupting fluid balance. Nausea, vomiting and diarrhoea can increase fluid loss, while reduced appetite and a feeling of fullness may lead some people to drink less throughout the day.

This means that people taking semaglutide, liraglutide or tirzepatide should pay attention to hydration, particularly when gastrointestinal symptoms persist. The risk may also become more significant on very hot days, during physical activity or in the presence of conditions affecting kidney function.

Let us therefore look at why dehydration may occur during treatment with GLP-1 medicines, which signs to look out for and how to prevent fluid loss from causing more serious consequences.

Is dehydration a common side effect of GLP-1 receptor agonists?

Dehydration may occur during treatment with GLP-1 receptor agonists, although it does not necessarily affect everyone taking these medicines. The most common adverse reactions generally involve the gastrointestinal system. These symptoms can lead to excessive fluid loss or a reduction in the amount of water consumed throughout the day. For this reason, it is important to take precautions during treatment to help prevent significant fluid loss.

It is therefore correct to consider dehydration a possible consequence of gastrointestinal side effects and reduced fluid intake. The medicine does not automatically remove water from the body. The risk emerges when fluid losses become substantial or when feeling unwell makes it difficult to drink enough.

Greater attention is required at the beginning of treatment and during the dose-escalation phase. During these periods, nausea, vomiting and diarrhoea may appear or become more intense. Mild nausea alone does not indicate that a person is dehydrated. It is important, however, to observe whether the symptom prevents the person from drinking, whether repeated episodes of vomiting or diarrhoea occur or whether urine output decreases significantly. These factors can help identify when normal gastrointestinal discomfort is beginning to disrupt fluid balance.

How GLP-1 medicines can contribute to dehydration

Dehydration during treatment with GLP-1 medicines may develop through two pathways. In the first case, the body loses fluids because of persistent gastrointestinal symptoms. In the second, nausea, a feeling of fullness and reduced appetite make drinking throughout the day feel less natural.

These mechanisms may also overlap. A person experiencing episodes of vomiting or diarrhoea, for example, should replace the fluids they have lost, but feeling unwell may make it difficult to drink enough water. The risk therefore depends on the duration and intensity of the symptoms, as well as on individual circumstances.

Nausea, vomiting and diarrhoea

Nausea, vomiting and diarrhoea are among the gastrointestinal side effects associated with medicines such as semaglutide, tirzepatide and liraglutide. Nausea alone does not necessarily cause fluid loss, but it may reduce the desire to drink, particularly when it persists for several hours or returns after meals.

Vomiting and diarrhoea have a more direct effect on fluid balance. Through these symptoms, the body loses water and mineral salts. When episodes are repeated and fluids are not replaced, the loss may become more rapid than can be perceived through thirst alone.

The prescribing information for semaglutide, tirzepatide and liraglutide explicitly links gastrointestinal reactions to possible volume depletion.

The risk requires greater attention when symptoms appear after treatment begins or following a dose increase. Gradual dose titration is used specifically to improve gastrointestinal tolerability, but it does not rule out the possibility that these symptoms may become severe enough to compromise fluid intake.

Reduced appetite and lower fluid intake

GLP-1 receptor agonists promote satiety and may reduce interest in food. This effect is part of their therapeutic mechanism, but it may also change certain everyday habits. People who eat smaller portions, skip a snack or feel full for many hours may take in less fluid through food and may remember to drink less frequently.

In this case, dehydration does not result from an obvious loss, as happens with vomiting or diarrhoea. Instead, it develops when water intake remains insufficient for a prolonged period. The risk may go unnoticed because the person does not immediately associate tiredness, a dry mouth or more concentrated urine with having drunk too little.

Even mild nausea can contribute. Some people avoid drinking because they are concerned that it will increase the feeling of fullness or because consuming large amounts at once causes discomfort. This does not mean that the medicine automatically eliminates the sensation of thirst. It is more accurate to say that its effects on appetite and gastrointestinal tolerability may make fluid intake less regular.

Weight loss does not in itself indicate dehydration. A reduction in weight achieved during treatment is different from a rapid decrease caused by water loss. The point to monitor is therefore not only what the scales show, but also how much the person is able to drink, whether gastrointestinal symptoms are present and whether there are any changes in urine output.

This mechanism becomes particularly important when reduced intake is combined with hot weather, physical activity or other conditions that increase fluid requirements. Before looking at prevention strategies, however, it is necessary to recognise the signs through which the body may indicate that hydration is no longer sufficient.

Symptoms and signs of dehydration that should not be overlooked

Symptoms of dehydration may develop gradually and, in the early stages, can easily be confused with other effects experienced during treatment with GLP-1 medicines. To interpret them correctly, it is useful to consider not only the individual symptom, but also the amount of fluid consumed, the presence of vomiting or diarrhoea and any changes in urine output.

Dry mouth, headache, tiredness and dizziness

A dry mouth and more intense thirst than usual may be among the first signs of insufficient fluid intake. Headache, tiredness or a general feeling of weakness may also occur. These symptoms are not very specific, however, and cannot on their own establish whether dehydration is present.

During treatment with semaglutide, liraglutide or tirzepatide, these symptoms should be interpreted in context. If the person has drunk very little for several hours, has experienced episodes of vomiting or diarrhoea and also has a dry mouth, a connection with fluid loss becomes more plausible. By contrast, an isolated headache may have many other causes and should not automatically be attributed to the medicine or to dehydration.

Dizziness may also occur when fluid volume decreases and blood pressure tends to fall, particularly when moving from a sitting or lying position to standing. In more pronounced cases, the feeling of unsteadiness may be accompanied by blurred vision, sudden weakness or a feeling of faintness. Dehydration and hot weather are among the possible conditions that may contribute to a temporary loss of consciousness.

Dizziness, trembling or weakness do not always indicate a lack of fluids. In people with diabetes, they may also be caused by a fall in blood glucose, particularly when a GLP-1 medicine is used alongside insulin or medicines such as sulphonylureas. For this reason, when symptoms are sudden or recurrent, it is important to follow the instructions provided for blood glucose monitoring and report the episode to a doctor.

The relationship between these medicines and feelings of unsteadiness is also explored in the content dedicated to dizziness caused by GLP-1 medicines. In this context, the most useful point is to observe whether dizziness is accompanied by reduced water intake, gastrointestinal symptoms or noticeable changes in urine output.

Dark urine, reduced urine output and low blood pressure

A reduction in the amount of urine produced may indicate that the body is trying to preserve the fluids available. A more intense yellow colour than usual may also be compatible with more concentrated urine, particularly if the change appears after drinking very little or in the presence of vomiting and diarrhoea.

Urine colour, however, should not be used as the only indicator. It may also vary depending on food, supplements and certain medicines. It is more useful to consider the combination of signs: if the person is urinating much less than usual, their mouth remains dry and their weakness increases, the fluid deficit may have become more significant.

Volume loss may also contribute to a fall in blood pressure. A person may notice this because they feel dizzy when standing up, need to sit down again or experience unusual weakness. Anyone taking antihypertensive medicines or diuretics should pay particular attention to these changes and speak to their doctor without altering their treatment independently.

A marked reduction in urine output also requires attention because dehydration associated with gastrointestinal reactions may contribute to acute kidney injury.

These signs should not be used for self-diagnosis. Instead, they can help identify when the body may no longer be able to compensate for lost fluids. The likelihood of this happening also depends on age, kidney function and environmental conditions, all of which require a different level of attention from one person to another.

Who should take greater care during treatment?

Dehydration can affect anyone experiencing vomiting, diarrhoea or a prolonged reduction in fluid intake. Certain personal circumstances, however, may make it more difficult to compensate for fluid losses and increase the consequences of insufficient hydration.

The level of attention required should also take account of other treatments being used and the activities carried out during the day. A mild gastrointestinal symptom may become more significant when it coincides with high temperatures, heavy sweating or a clinical condition requiring careful management of fluid balance.

Older people, people with diabetes and patients with kidney problems

Older people may be more vulnerable to dehydration, particularly when they live with several medical conditions or take multiple medicines. In this age group, it may also be more difficult to maintain regular water intake, especially in cases of reduced independence, mobility problems or persistent discomfort. Hot weather can further increase the risk and therefore requires closer monitoring of drinks consumed and urine output.

People with diabetes should also monitor any changes carefully. High blood glucose may increase thirst and urine production, contributing to greater water loss. If nausea, vomiting or diarrhoea associated with treatment are added to this mechanism, replacing fluids may become more difficult. The risk therefore does not depend on the diagnosis of diabetes alone, but also on blood glucose control, general health and the other treatments being used.

Particular caution is required in the presence of pre-existing impaired kidney function.

Care should also be taken with diuretics and certain medicines used to treat high blood pressure. These treatments may affect fluid balance or increase vulnerability during hot weather. They should not be stopped or altered independently: the doctor will assess whether monitoring or temporary adjustments are necessary.

Hot weather, physical activity and heavy sweating

During hot and humid weather, the body loses water through sweat in order to regulate body temperature. Physical activity increases this loss, particularly when it is carried out outdoors or during the hottest part of the day. If the person is already drinking less because of nausea or has experienced episodes of vomiting or diarrhoea, the combination of these factors may make dehydration more likely.

People being treated with GLP-1 medicines do not necessarily need to give up exercise. It is useful, however, to plan physical activity during the cooler parts of the day, adapt its intensity to the weather conditions and drink regularly without waiting for thirst to become intense.

The amount of fluid required varies according to the duration of the activity and the amount of sweating. For this reason, the same approach should not automatically be applied to everyone. Short, moderate activity requires different management from several hours of physical work or exercise in hot conditions, during which it may also become important to replace electrolytes lost through sweat.

Fever may also increase water requirements. When it occurs alongside vomiting or diarrhoea, the person’s ability to drink and the frequency of urination should be monitored more carefully. If fluids cannot be retained or the person’s general condition worsens, medical advice should be sought without waiting for more pronounced signs to develop.

How to prevent dehydration during GLP-1 treatment

Preventing dehydration does not mean drinking large quantities of water all at once. It is more useful to maintain regular fluid intake throughout the day and adapt it to actual fluid losses, environmental conditions and the advice provided by a doctor. This becomes even more important when nausea makes drinking difficult or when episodes of vomiting and diarrhoea occur.

Fluid requirements may increase in hot weather, during prolonged physical activity or in the presence of fever. They may also change if vomiting and diarrhoea cause a significant loss of fluid. By contrast, some people with kidney disease, heart conditions or other medical problems may have received specific guidance on how much they should drink. In these cases, fluid intake should not be increased independently, and the plan established by the healthcare professional should be followed.

Drinking at regular intervals helps prevent reaching the end of the day with an already significant deficit. It may be useful to keep a bottle close at hand and spread water intake between meals rather than relying exclusively on thirst. When nausea is present, drinking large glasses quickly may increase the feeling of fullness. It is preferable to begin with small sips and gradually increase the amount according to tolerance.

The same approach may be used after an episode of vomiting. If even small amounts are brought back up or it becomes impossible to replace the fluids lost, continuing to manage the problem at home may not be sufficient. It will then be appropriate to contact a doctor to assess the situation and receive advice suited to the individual’s circumstances.

Diet, electrolytes and everyday habits

Reduced appetite can alter the entire eating routine. For this reason, nutritional support during GLP-1 treatment should consider not only calories, but also the regularity with which fluids and nutrients are consumed.1 Hydration does not depend solely on the water that is drunk. Part of daily fluid intake also comes from food. Fruit, vegetables, soups and other water-rich foods may contribute to the total, provided they are well tolerated and included in a diet consistent with the treatment pathway.

During periods of nausea, it may be easier to choose smaller portions and minimally processed foods, avoiding the consumption of large quantities of food and drink at the same time. The aim is not to force oneself to eat, but to find ways of continuing to consume fluids without worsening the discomfort.

Electrolytes are not automatically necessary for everyone undergoing treatment with semaglutide, tirzepatide or liraglutide. In everyday life, a regular diet and adequate water intake are generally sufficient to maintain fluid and mineral balance. When vomiting or diarrhoea cause substantial losses, however, an oral rehydration solution may help replace water, salts and glucose in proportions formulated to support absorption.

Oral rehydration solutions should not be confused with any sports drink or mineral salt supplement. The appropriate choice depends on the extent of the losses and the person’s health. Anyone with kidney problems, potassium imbalances, high blood pressure or other medical conditions should seek advice from a doctor or pharmacist before regularly using products containing electrolytes.

Alcoholic drinks also require caution, particularly during hot weather or when water intake is already reduced. Coffee and other caffeinated drinks do not need to be prohibited completely, but they should not systematically replace water or aggravate existing nausea, diarrhoea or gastric discomfort. Recommendations for preventing heat-related health problems advise prioritising water and limiting alcohol and drinks that are very high in caffeine or sugar.

Supplements may form part of a broader nutritional support strategy, but they do not treat dehydration and do not replace fluid replenishment. Products presented as effective supplements against GLP-1 side effects should also be assessed according to their composition, current treatments and the doctor’s advice. The same principle applies to natural supplements for the metabolism, which may support general wellbeing without taking on the role of a treatment for vomiting, diarrhoea or fluid loss.

Maintaining a hydration routine helps reduce the risk, but it is not always sufficient when symptoms continue. It is therefore important to know when the problem can be managed with greater care at home and when it becomes necessary to seek medical assistance.

Maintaining hydration during GLP-1 treatment

As we have explained, GLP-1 receptor agonists do not inevitably cause dehydration. The risk increases mainly when gastrointestinal symptoms cause fluid loss or when nausea, early satiety and reduced appetite lead a person to drink less.

Paying attention to the amount of water consumed, spreading fluid intake throughout the day and observing any changes in urine output can help identify a possible imbalance sooner. When vomiting or diarrhoea persist, however, home management alone may not be sufficient, and it becomes important to seek advice from a doctor.

Within the nutraceutical sector, interest is growing in formulations designed to provide hydration support during GLP-1 treatment, particularly when reduced appetite changes the usual intake of food and drink.2

Supplements do not replace water, oral rehydration solutions recommended by a healthcare professional or the treatment of a possible complication. They can only form part of a broader, personalised nutritional support pathway. At Cor.Con. International, we develop consumer healthcare solutions and natural supplements for maintaining wellbeing, which should always be assessed according to individual needs and current treatments.

Recognising the first signs and responding cautiously makes it possible to approach treatment with greater awareness, without considering dehydration an inevitable consequence and without underestimating it when the body is no longer able to replace the fluids it has lost.

References

  1. Nuovi farmaci anti obesità e integrazione nutrizionale: un approccio complementare e necessario – https://www.damianogalimberti.it/blog/farmaci-anti-obesita-integrazione-nutrizionale/ ↩︎
  2. 𝐓𝐡𝐞 𝐎𝐳𝐞𝐦𝐩𝐢𝐜 𝐞𝐜𝐨𝐧𝐨𝐦𝐲 𝐢𝐬 𝐛𝐨𝐨𝐦𝐢𝐧𝐠. 𝐁𝐮𝐭 𝐢𝐭’𝐬 𝐦𝐢𝐬𝐬𝐢𝐧𝐠 𝐚 𝐯𝐢𝐭𝐚𝐥 𝐢𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭: 𝐓𝐡𝐞 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧. – https://www.linkedin.com/posts/julian-cibotaru_nutraceuticals-glp1-productdevelopment-share-7442885316933406722-KR7_/?rcm=ACoAAAXFbPMBPwyklZxIlGPwb007fYaIa2vj1m0 ↩︎